Clinical trial
Liraglutide 3.0mg/d for the Treatment of Binge Eating Disorder
NCT03279731 is registered in ClinicalTrials.gov with Kelly Allison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Liraglutide 3.0mg/d for the Treatment of Binge Eating Disorder
- Lead sponsor
- Kelly Allison
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- September 29, 2017
- Completion date
- October 1, 2019
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.